Search This Blog

Wednesday, August 13, 2025

Trump: ‘unfair’ media quoting ‘fired losers’ ahead of high-stakes meeting with Putin

 President Trump raged against the “unfair” media over their coverage of his high-stakes summit with Russian tyrant Vladimir Putin in Alaska on Friday.

“Very unfair media is at work on my meeting with Putin. Constantly quoting fired losers and really dumb people like John Bolton, who just said that, even though the meeting is on American soil,” Trump seethed on Truth Social Wednesday.

“‘Putin has already won.’ What’s that all about? We are winning on EVERYTHING. The Fake News is working overtime (No tax on overtime!). If I got Moscow and Leningrad free, as part of the deal with Russia, the Fake News would say that I made a bad deal! But now they’ve been caught,” he added.

President Trump took aim at the media’s coverage of his high-stakes meeting with Putin Wednesday.REUTERS
Trump is meeting with Putin in Alaska to discuss the Ukraine war on Friday, August 15.AP

Leningrad reverted to its pre-Bolshevik name, St. Petersburg, in 1991.

Trump’s anticipated meeting at Joint Base Elmendorf-Richardson with Putin will mark the first time the Russian leader sets foot on US soil in about a decade. It will also be Putin’s first in-person meeting with a US president since he began the brutal invasion of Ukraine in 2022.

Former US national security adviser John Bolton spoke out against the summit.ZUMAPRESS.com

Since returning to the White House in January, Trump has made ending the bloody war in Ukraine one of his top foreign policy objectives. Over recent months, he has soured on Putin over the brutal Russian drone and missile strikes on Ukrainian civilians. 

Critics such as Trump’s former national security adviser John Bolton have argued that the president will be welcoming a “rogue leader of a pariah state” into the US and that Putin will attempt to “take advantage” of him. 

The Friday summit meeting comes after special envoy Steve Witkoff met with the Russian leader at the Kremlin last week, ahead of Trump’s deadline for Moscow to move toward peace or else the US would work to cut off its oil exports using steep economic penalties. 

Zelensky will not be at the summit, the White House confirmed.REUTERS

Details about Putin’s exact conditions for bringing about an end to his country’s war are murky and have drawn confusion from European allies.

Ukrainian President Volodymyr Zelensky has publicly cast doubt on making significant territorial concessions to Russia and underscored that Ukraine must have a say in any potential deal. 

Trump slammed the media for quoting “fired losers” and singled out “really dumb” John Bolton.CNN

The Trump administration is working toward a trilateral summit among Trump, Putin and Zelensky and sees the Alaska meeting as a step toward that goal, according to Vice President JD Vance. 

One of Trump’s close allies, NATO Secretary General Mark Rutte, has claimed the president is “testing” Putin and trying to gauge his openness to peace. 

Secretary of State Marco Rubio similarly implied that Trump is attempting to get a better sense of whether the Russian dictator is open to peace. 

President Trump meets with Russian President Vladimir Putin at the G-20 Summit on July 7, 2017, in Hamburg, Germany.AP

“The president talked to Putin on the phone three times or four times. Okay. And nothing has come of it — or at least we haven’t gotten to where we want to be,” Rubio told “Sid and Friends in the Morning” on Tuesday.

“So the president feels like, ‘Look, I’ve got to look at this guy across the table. I need to see him face-to-face,'” he added. “‘I need to make an assessment by looking at him.'”

https://nypost.com/2025/08/13/world-news/trump-slams-media-coverage-ahead-of-high-stakes-putin-meeting/

FDA may revoke Pfizer COVID-19 vaccine authorization for kids under certain age

 The U.S. Food and Drug Administration (FDA) may not renew the Emergency Use Authorization for the Pfizer-BioNTech COVID-19 vaccine for children under the age of five, the company said. 

The possible move would pull the only available coronavirus vaccine for young children from the market. 

"We are currently in discussions with the agency on potential paths forward and have requested that the EUA for this age group remain in place for the 2025-2026 season," a spokesperson for Pfizer said in a statement to Fox News Digital.

"It is important to note that these deliberations are not related to the safety and efficacy of the vaccine which continues to demonstrate a favorable profile," it said. 

Children aged 6 months to 4 years "[w]ho are moderately or severely immunocompromised" may take a Moderna shot, according to the Centers for Disease Control and Prevention's (CDC) child immunization schedule.

Otherwise, different recommendations are made for the 5-11 and 12-17-year age ranges. 

TickerSecurityLastChangeChange %
PFEPFIZER INC.24.95+0.32+1.30%

"The COVID-19 pandemic ended with the expiration of the federal public health emergency in May 2023," an HHS spokesperson said in a statement to Fox News Digital, adding that the department does "[n]ot comment on potential, future regulatory changes."

"Unless officially announced by HHS, discussion about future agency action should be regarded as pure speculation," it said. 

Back in May, Health and Human Services (HHS) Director Robert F. Kennedy Jr. sent out a post on X that read, "[T]he COVID vaccine for healthy children and healthy pregnant women has been removed from @CDCgov recommended immunization schedule." 

"[W]e are prioritizing the restoration of public trust above any specific pro- or anti-vaccine agenda," Kennedy said in June. "The public must know that unbiased science—evaluated through a transparent process and insulated from conflicts of interest—guides the recommendations of our health agencies."

https://www.foxbusiness.com/economy/fda-may-revoke-pfizer-covid-19-vaccine-authorization-kids-under-certain-age

New Details Emerge About Golden Dome's Four-Layer Missile Defense Shield

 The "Hemispheric Defense" theme is gaining momentum with new details emerging that the Golden Dome missile defense system will comprise of four layers: one space-based and three ground-based, including 11 short-range batteries positioned across the continental U.S., Alaska, and Hawaii. 

Reuters cited a U.S. government slide presentation on the project, titled "Go Fast, Think Big!", which was presented to 3,000 defense contractors in Huntsville, Alabama, last week. Think of the Golden Dome as Israel's Iron Dome on serious steroids, given its complexity and scale. 

According to the slides, the Golden Dome's missile defense shield architecture calls for:

  • Space layer: satellites for missile warning, tracking, and boost-phase interception.

  • Upper layer: Next Generation Interceptors (NGI), THAAD, and Aegis systems — with a new missile field likely in the Midwest.

  • Under layer: Patriot systems, new radars, and a common launcher for current and future interceptors.

Reuters noted:

One surprise was a new large missile field - seemingly in the Midwest according to a map contained in the presentation - for Next Generation Interceptors (NGI) which are made by Lockheed Martin (LMT.N), opens new tab and would be a part of the "upper layer" alongside Terminal High Altitude Area Defense (THAAD) Aegis systems which Lockheed also makes.

NGI is the modernized missile for the Ground-Based Midcourse Defense (GMD) network of radars, interceptors and other equipment - currently the primary missile defense shield to protect the United States from intercontinental ballistic missiles from rogue states.

The U.S. operates GMD launch sites in southern California and Alaska. This plan would add a third site in the Midwest to counter additional threats.

The Pentagon pointed out challenges such as communication latency across the kill chain (a step-by-step sequence of actions needed to find, target, and destroy a threat). Major defense contractors on the project include Lockheed Martin, Northrop Grumman, RTX, and Boeing; SpaceX was absent from the latest plans. 

In recent months, Goldman analyst Noah Poponak identified for clients a clear investment opportunity tied to deploying Golden Dome shields across the Homeland to shoot down hypersonic missile threats.

Poponak said: "We are Buy-rated on L3Harris because management expects its organic revenue growth rate to accelerate in 2026, margins to continue expanding, and strong free cash flow growth going forward."

Latest coverage on the hemispheric defense theme:

Space Force Gen. Michael Guetlein is the program lead and must deliver the first designs within 60 days and a complete roadmap of the project within 120 days. The dome's goal is to intercept missiles in their boost phase and deploy relocatable defenses capable of rapid global deployment. This comes amid an emerging and dangerous bipolar world that will only worsen in the 2030s. 

https://www.zerohedge.com/military/new-details-emerge-about-golden-domes-four-layer-missile-defense-shield

Biden's Decline Was Worse Than Anyone Knew: Comer

 Via VigilantFox.com,

Rep. Comer says that the cover-up is far more extensive than previously imagined.

“This is more evidence that there was a cover up to try to conceal to the American public, Joe Biden’s mental decline and physical decline.”

He points to internal emails and memos — including one warning Biden couldn’t walk a short flight of steps on a ship — as proof everyone knew.

Comer’s committee is investigating the autopen used to sign orders and pardons during Biden’s final 90 days.

“What’s at stake… is to determine whether or not those executive orders and those pardons… are valid.”

If the courts agree, Biden’s final acts as president could be wiped from the books.

https://www.zerohedge.com/political/bidens-decline-was-worse-anyone-knew-comer

LIXTE Biotechnology adopts cryptocurrency treasury policy

 LIXTE Biotechnology Holdings (LIXT) announced that its board of directors approved a treasury policy allowing up to 25% of corporate reserves to be allocated to cryptocurrencies, including Bitcoin and other digital assets.

The clinical-stage pharmaceutical company stated that all digital assets will be held with a regulated custodian and transactions will comply with financial, legal and audit standards. The policy is designed to diversify the company’s treasury management approach.

"LIXTE’s updated treasury policy is based on our conviction in the long-term potential of cryptocurrency to hedge our existing treasury assets, as well as delivering meaningful returns for shareholders," said Geordan Pursglove, chairman and CEO of LIXTE.

The company indicated the cryptocurrency allocation aims to hedge against inflation and currency depreciation while enhancing liquidity through globally recognized digital assets. LIXTE also cited positioning itself within fintech-enabled financial strategy as a rationale for the policy change.

LIXTE develops cancer therapeutics targeting the protein phosphatase 2A pathway. The company’s lead compound, LB-100, is a PP2A inhibitor currently in proof-of-concept trials for ovarian clear cell carcinoma, metastatic colon cancer and advanced soft tissue sarcoma.

https://www.investing.com/news/cryptocurrency-news/lixte-biotechnology-adopts-cryptocurrency-treasury-policy-432SI-4188406

Military-Grade Fentanyl Protection: Tharimmune Secures Global Patent Shield Through 2040



Tharimmune (Nasdaq:THAR) has secured significant global patent protection for TH-104, its novel transmucosal film technology, extending coverage until at least 2040. The patents, granted in Japan, Mexico, Australia, and the United States, cover a unique method for administering nalmefene via a single-layer, mucoadhesive film.

The FDA has provided positive feedback on TH-104's NDA pathway, confirming that a 505(b)(2) submission is viable for preventing respiratory and CNS distress, with no additional clinical trials required for military and first responder use against weaponized opioids. The drug features a longer half-life compared to existing alternatives like Narcan®, potentially providing sustained protection in high-risk environments.